LOG IN
Analysis
Featured Analysis
Articles by Category
Current Editions
Data Graphics
Discovery & Translation
Hot Topics
BioCentury Podcasts
Special Reports & Presentations
White Papers
BCIQ Data
BCIQ
Company Profiles
Product Profiles
Target Profiles
Financial Dashboards
Events
All Events
East-West Healthcare Reception
Bio€quity Europe
Grand Rounds — U.S.
Grand Rounds — Europe
China Healthcare Summit
East-West Biopharma Summit 2026
Bio€quity Europe 2026
The BioCentury Show
Podcast: BioCentury This Week
Webinars
My Workspace
About BioCentury
Management
Analysts & Research Team
Scientific Advisory Board
Contact
Contact Us
Forgot Password
Request a Subscription
Sponsorship & Branding Inquiry
Media Kit
Request BioCentury's BCIQ Brochure
Customer Resource Center
Career Opportunities
Request a Trial
Company Profiles
Target Profiles
Product Profiles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Company Profiles
Target Profiles
Product Profiles
China Healthcare Summit
Bio€quity Europe
Explore BCIQ profiles by entering a product name.
REQUEST A FREE TRIAL
Product
Deals
Articles
BioCentury
|
Mar 19, 2001
Clinical News
OSI-774 (CP-358,774): Began Phase Ib trial
Read More
BioCentury
|
Nov 13, 2000
Clinical News
OSI-774: Phase II
Read More
BioCentury
|
Sep 18, 2000
Clinical News
OSI-774: Phase II
Read More
BioCentury
|
Sep 18, 2000
Clinical News
OSI-774: Phase II
Read More
BioCentury
|
Jul 3, 2000
Analyst Picks & Changes
Analyst picks & changes
Read More
BioCentury
|
Jun 26, 2000
Clinical News
CP-358,774 (OSI-774): Completed Phase II study enrollment
Read More
BioCentury
|
Jun 26, 2000
Finance
A little quirky
Read More
BioCentury
|
Jun 26, 2000
Company News
OSI, Pfizer deal
Read More
BioCentury
|
Jun 26, 2000
Regulation
Serendipity makes OSI a Phase II player
Read More
BioCentury
|
Jun 19, 2000
Top Story
OSI gets full rights to cancer compound
Read More
Items per page:
10
1 - 10 of 12
